Atlas Trials

Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)

Clinical trial NCT02980991 · COMPLETED

Trial details

NCT number
NCT02980991
Sponsor
Fudan University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Adenocarcinoma
Start date
2015-12-01
Primary completion
2018-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.